Plain-English translation of NCT07283081 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
This study doesn't follow the usual testing phases โ it may be an observational study or a different type of research.
This research is exploring whether capillaroscopy โ a safe, quick, non-invasive test that examines the tiny blood vessels in your skin โ can help doctors figure out what's causing your newly diagnosed interstitial lung disease. The test is already used to screen for certain autoimmune conditions, but doctors aren't sure if it should be part of the standard workup for all patients with lung disease. This study aims to find out if capillaroscopy can give your doctor important clues about whether your lung disease is connected to an underlying autoimmune condition.
About one in five cases of interstitial lung disease are linked to autoimmune disorders like scleroderma or lupus, which can be hard to diagnose early. Capillaroscopy can spot early signs of these conditions, but there's no clear guidance on whether all lung disease patients should have this test as part of their initial evaluation. This study will help determine if adding capillaroscopy to standard testing improves the speed and accuracy of diagnosis.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
If you join this study, you'll have a capillaroscopy performed โ a painless, 10-15 minute scan where a special microscope looks at the tiny blood vessels at the edge of your fingernail bed. You'll also complete a questionnaire about your symptoms. At the same time, your doctors will do their standard workup to diagnose your lung disease, including blood tests, imaging, and breathing tests. After about three months, once all tests are complete, your lung specialist will review everything together to determine the likely cause of your disease. The only test that's extra for research purposes is the capillaroscopy; everything else is part of your normal care.
AI-generated summary from trial data ยท Sep 5, 2026 ยท Not medical advice
France